SCHEMBL1004032

SCHEMBL1004032

CCCCN(CCCC)C(=O)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.71
GAA P10253 1/20 0.71
HDAC1 Q13547 2/20 0.64
HDAC6 Q9UBN7 2/20 0.64
HDAC3 O15379 1/20 0.59
HDAC2 Q92769 1/20 0.59
LTB4R2 Q9NPC1 1/20 0.59
EGFR P00533 1/20 0.59
ERBB2 P04626 1/20 0.59
ALDH1A1 P00352 3/20 0.58
LIMK1 P53667 1/20 0.53
LIMK2 P53671 1/20 0.53
TP53 P04637 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27488430 0.96 HPGD (0.71) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL11357038 0.93 HPGD (0.70) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL18274820 0.93 HPGD (0.62) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL1005865 0.93 HPGD (0.82) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL8378738 0.93 HPGD (0.62) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL10695878 0.93 HPGD (0.62) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL8374583 0.93 HPGD (0.62) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL27756463 0.92 HPGD (0.61) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL11319566 0.92 HPGD (0.61) HPGDGAAHDAC1HDAC6HDAC3
SCHEMBL6674114 0.90 EGFR (0.70) HPGDGAAHDAC1HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109286041-A Electrolyte and secondary lithium battery 宁德时代新能源科技股份有限公司 2019-01-29 CN claimed
US-20080081759-A1 PROCESS FOR THE PREPARATION OF GLYCOLALDEHYDE EASTMAN CHEMICAL COMPANY (US) 2008-04-03 US claimed
US-7301054-B1 Process for the preparation of glycolaldehyde EASTMAN CHEMICAL COMPANY (US) 2007-11-27 US claimed
WO-2003047572-A1 USE OF 1-PHENYL-OXAZOLIDINE-2-ONE COMPOUNDS AS PROTEASE M INHIBITORS MERCK PATENT GMBH (DE) 2003-06-12 WO claimed
US-6231784-B1 FOR EXTRACTION OF METAL VALUES, PARTICULARLY COPPER VALUES, IN EXTRACTION FROM AQUEOUS SOLUTIONS, IN WHICH EXTRACTANT AND MODIFIERS ARE EMPLOYED IN ORGANIC SOLVENT PHASE, SOLVENT BEING WATER INSOLUBLE, WATER IMMISCIBLE HYDROCARBON HENKEL CORPORATION 2001-05-15 US claimed
US-4115204-A Separation of phenol-, cyclohexanone-, and cyclohexylbenzene-containing mixtures employing an N,N-disubstituted amide PHILLIPS PETROLEUM COMPANY (US) 1978-09-19 US claimed
CN-111574477-B Synthesis method of amide compound 湖南大学 2024-06-28 CN disclosed
CN-116283640-B Method for synthesizing amide by photocatalytic aldehyde 湖南省林业科学院 2024-06-18 CN disclosed
CN-116283640-A Method for synthesizing amide by photocatalytic aldehyde 湖南省林业科学院 2023-06-23 CN disclosed
US-11518889-B2 Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion CANON KABUSHIKI KAISHA (JP) 2022-12-06 US disclosed
CN-111018735-B Preparation method of cinnamamide compound 河南农业大学 2021-09-07 CN disclosed
CN-109286041-B Electrolyte and secondary lithium battery 宁德时代新能源科技股份有限公司 2020-12-11 CN disclosed
US-20200270463-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION CANON KABUSHIKI KAISHA (JP) 2020-08-27 US disclosed
EP-0306025-A2 Process for producing polyarylene sulfide IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1989-03-08 EP disclosed
US-4497887-A Thermal development type diazo copying material with hydrophobic resin encapsulated coupler particle Ricoh Compay, Ltd. (JP) 1985-02-05 US disclosed
US-4171975-A MAGENTA COUPLER AND AN AMIDE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1979-10-23 US disclosed
US-4170614-A HYDROLYSIS OF TRIS(2,6-DIHALOPHENYL) PHOSPHATE PPG INDUSTRIES, INC. (US) 1979-10-09 US disclosed
US-4115204-A Separation of phenol-, cyclohexanone-, and cyclohexylbenzene-containing mixtures employing an N,N-disubstituted amide PHILLIPS PETROLEUM COMPANY (US) 1978-09-19 US disclosed
US-4059655-A REACTING A 2,6-DIHALOPHENOL WITH PHOSPHORUS OXYHALIDE, HYDROLYSIS PPG INDUSTRIES, INC. (US) 1977-11-22 US disclosed
US-3941783-A Process for the production of N,N-disubstituted carboxylic amides ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) 1976-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200270463-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION GRIA1, GRIN1, NR3C1 HPGD 1916/4885GAA 2467/4885HDAC1 623/4885
US-11518889-B2 Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion GRIA1, GRIN1, NR3C1 HPGD 1916/4885GAA 2467/4885HDAC1 623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.